The Food and Drug Administration has approved Journavx (suzetrigine) for the treatment of moderate to severe acute pain in adults.

Biomedical microrobots could revolutionize future cancer treatments, reliably delivering targeted doses of toxic cancer-fighting drugs to destroy malignant tumours while sparing healthy bodily tissues ...

"The $7.3 billion is the difference between what they are reimbursing themselves and what it is estimated to cost them to acquire the drug," an FTC spokesperson told reporters in a press briefing ...

Drugmakers raised the list prices on 575 name-brand drugs in just the first two days of the new year, according to drug price research firm 46brooklyn. Drugs for diabetes, HIV, cancer saw price ...

(RTTNews) - French drug major Sanofi (SNY ... the non-proprietary name for Sarclisa is isatuximab-irfc, with irfc as the suffix designated in accordance with nonproprietary naming of biological ...

A chart staple since its release in 2017, Elton’s career-spanning hits collection finally surges to the summit in its 374th week on chart, bolstered by limited edition releases across brand-new ...

Too much of anything can be bad, and the consequence of too much of drugs is something we are all familiar with. Not all of us have tried these drugs, but cinema has shown us the most graphic and ...

Most of the 35,000 online pharmacies around the world are operating illegally and could be selling dangerous or ineffective drugs, according to the U.S. Trade Representative's annual "notorious ...

Billboard’s Top Billboard 200 Albums of the 21st Century chart reflects performance on weekly Billboard 200 charts dated Jan. 1, 2000, through Dec. 28, 2024. (Titles released prior to mid-1999 ...

Following the Official Singles Chart success of Angel Of My Dreams, Midnight Cowboy and Fantasy, JADE unleashes her first release of 2025; IT girl. A massive middle finger to the most fickle ...

Contractors are juggling optimism and unease entering 2025. From interest rate cuts to a new presidential administration, construction pros are keeping close tabs on key issues and trends that ...